Chicago Personal Injury Lawyer - Defective Drugs

Recall of Fentanyl Pain Management Patches

Jamie G. Goldstein — Wed, 20 Feb 2008 16:14:35 GMT

The FDA announced on February 19, 2008 that Actavis Inc. is recalling certain Fentyl transdermal patches. These patches may be defective causing an excess amount of medication to be administered to the patient. This overdose of medication can lead to respiratory depression and possible fatal overdose.

The recall extended to patches with doses of 25, 50, 75 and 100 mcg/hr. It is not known at this time if anyone has been injured as a result of these faulty patches, however, the manufacturer has recalled 14 lots of Fentanyl patches due to this fold over defect, which causes a possible overdose of medication.

If you or anyone you know has suffered from respiratory distress or death while on one of these patches, contact an attorney immediately. You may have a right to take legal action against the manufacturer, Actavis.

Originally posted at InjuryBoard by Jamie G. Goldstein

Bayer Suspends Marketing of Trasyol

Jamie G. Goldstein — Mon, 05 Nov 2007 11:05:54 GMT

The FDA announced today that it has requested Bayer Pharmaceuticals Corporation to suspend its marketing of Traysol. Bayer has agreed to the suspension. Traysol, is used to control patient bleeding during heart surgery, but recent studies have suggested it can cause patients an increased risk of death.

The FDA and Bayer are currently working to phase out Traysdol without causing a market shortage due to the few other drug treatments currently available. This suspension of the drug comes after a December 2006 change in the Traysdol's label warning patients of potential kidney damage.

It is too early to determine how many people have had adverse reactions to Traysdol, but if you or someone you know was given Traysdol during heart surgery and died as a result of the surgery or had serious side effects, contact an attorney immediately. You may be able to recover if the Traysdol caused the adverse event.

For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.

Originally posted at InjuryBoard by Jamie G. Goldstein

Provigil Label Revised

Jamie G. Goldstein — Fri, 26 Oct 2007 17:44:10 GMT

The FDA is notifying healthcare professionals about updates to the warning labels of the prescription drug Provigil. Provigil is used to help adult patients who suffer from sleep apnea, narcolepsy and other sleeping disorders. The revised label warns patients that Provigil may caused a serious rash that could include Stevens-Johnson Syndrome (SJS) and hypersensitivity reactions. It may also cause psychiatric symptoms. In some cases Toxic Epidermal Necrolysis may occur which may be life-threatening. This life-threatening rash along with Eosinophulia and Systemic Symptoms have been reported in adults and children since Provigil began being marketed. Angiodema and multi-organ hypersentivity reactions are also being reported as side effects to the medication.

If you or someone you know is suffering from or has suffered from any of the above side effects or similar side effects while taking Provigil, contact an attorney immediately. You may be able to recover from the manufacturer of the medication for these side effects that were not listed until the recent label change.

For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.

Originally posted at InjuryBoard by Jamie G. Goldstein

Advanced Medical Moisture Plus May Cause Blindness

Jamie G. Goldstein — Tue, 29 May 2007 16:49:05 GMT

Advanced Medical Moisture Plus Multi-Purpose contact solution was recalled after it was found it may cause blindness. The contact lens solution has been linked to a parasitic infection, Acanthamoeba keratitis. The FDA first announced the recall on May 26, 2007.

If you have been using Moisture Plus Multi-Purpose contact solution you should discontinue use at once. The symptoms related to the eye infection include eye pain, redness, excess tearing, blurred vision, as well as other symptoms. If you have developed an infection that may be linked to the solution, do not discard any remaining solution, contact lens cases or contact lens. Instead, keep these items in a safe area and contact an attorney immediately. You may be able to take legal action against the manufacturer.

Originally posted at InjuryBoard by Jamie G. Goldstein

Complete MoisturePlus Contact Lens Solution Recalled

Jamie G. Goldstein — Tue, 29 May 2007 16:28:32 GMT

The FDA announced on May 26, 2007, that Advanced Medical Optics voluntarily recalled its Complete MoisturePlus contact lens solution. The recall was made after the company received reports of people developing Acanthamoeba keratitis, a type of serious eye infection. Contact lens owners who use this solution should stop using it immediately.

The FDA suggests that consumers throw away the unused solution, however, if you have suffered from an eye infection after using the solution, do not discard it. Keep the solution in a safe area and contact an attorney.

This recall comes approximately one and a half years after the recall of Bausch and Lomb's Renu with MoistureLoc. That solution was also reported to cause severe eye infections and several lawsuits are currently pending against the manufacturer.

Originally posted at InjuryBoard by Jamie G. Goldstein

Avandia May Increase Risk of Heart Attack

Jamie G. Goldstein — Thu, 24 May 2007 09:30:37 GMT

The FDA posted a warning on May 21, 2007 regarding the type 2 diabetes drug Avandia. Studies show that the drug may cause significant increased risk of heart attack. However, other studies have not shown the same results. Patients taking Avandia are urged to speak with their doctors about potential risks.

If the studies are true that patients taking Avandia are at 30-40 percent greater risk of having a heart attack or other heart related problems, serious concerns would be raised about whether the drug is safe for people to take. Patients that suffer from diabetes already have an increased risk of heart disease. Depending on the outcome of the current and future studies, people taking Avandia that have previously suffered from a heart attack or heart problems while on Avandia may be able to take legal action against the GlaxoSmithKLine, the manufacturer of the drug.

Originally posted at InjuryBoard by Jamie G. Goldstein

Colonoscopy Drug Leads to Renal Failure

Jamie G. Goldstein — Fri, 18 May 2007 13:15:17 GMT

A Texas woman recently filed suit against C.B. Fleet Company after she suffered acute renal failure and other side effects after using the companies Phospho soda solution. The solution is used by many patients prior to undergoing a colonoscopy in order to cleanse the patient's bowels. The lawsuit alleges that the solution causes renal failure and other side effects when it is taken in by patients that use certain blood pressure medications.

The lawsuit goes on to allege that the damage to the woman was avoidable because C.B. Fleet Company knew for at least 12 years about the potential harmful side effects of the drug when it was combined with certain blood pressure medications. There are no warnings on the product that it may be dangerous when taken in combination with certain blood pressure medications. It is likely that there are other people that have been adversly affected by using C.B. Fleet Company's Phospho soda solution and they may be entitled to take legal action against the company.

Originally posted at InjuryBoard by Jamie G. Goldstein